Fatimah Al-Ani1, Salimah Shariff2, Lenicio Siqueira1, Ayman Seyam1, Alejandro Lazo-Langner3. 1. Department of Medicine, Division of Hematology, University of Western Ontario, London, ON, Canada. 2. Institute for Clinical Evaluative Sciences - Western (ICES Western), London, ON, Canada. 3. Department of Medicine, Division of Hematology, University of Western Ontario, London, ON, Canada; Institute for Clinical Evaluative Sciences - Western (ICES Western), London, ON, Canada; Department of Epidemiology and Biostatistics, University of Western Ontario, London, ON, Canada. Electronic address: alejandro.lazolangner@lhsc.on.ca.
Abstract
BACKGROUND: Administrative data can be used to identify venous thromboembolism (VTE) and major bleeding (MB) events. However, the validity of this data in emergency room discharge records in Canada is unknown. METHODS: We conducted a single-institution retrospective chart re-abstraction study in London, Canada. We identified all adult patients with a VTE or MB code included in the mandatory Canadian Institute for Health Information National Ambulatory Care Reporting System seen at our institution between July 2002 and March 2014. VTE was defined using the International Classification of Diseases, 10th revision (ICD-10CM) codes for deep venous thrombosis (DVT), and pulmonary embolism (PE) whereas MB was defined using codes for intracerebral hemorrhage, subarachnoid hemorrhage, subdural hemorrhage, upper, and lower gastrointestinal bleeding. A random sample of 50 patients was obtained for each condition. Two abstractors independently conducted blinded diagnostic adjudication using standard criteria. Agreement was calculated using kappa statistics. Positive predictive values were calculated for VTE, MB and each diagnosis. RESULTS: Overall, ICD-10CM codes demonstrated very good ability to identify major bleeding events (PPV 88%). Diagnostic codes performed particularly well for all intracranial and lower gastrointestinal bleeds. In contrast, ICD-10CM codes for VTE had moderate ability (PPV 49%). Diagnostic codes for PE performed better than those for DVT. CONCLUSION: Single ICD-10CM codes for venous thromboembolism have moderate predictive value for identifying DVT and PE in emergency room discharges. In contrast, codes for MB events have very good ability and it would be adequate to use them for research purposes.
BACKGROUND: Administrative data can be used to identify venous thromboembolism (VTE) and major bleeding (MB) events. However, the validity of this data in emergency room discharge records in Canada is unknown. METHODS: We conducted a single-institution retrospective chart re-abstraction study in London, Canada. We identified all adult patients with a VTE or MB code included in the mandatory Canadian Institute for Health Information National Ambulatory Care Reporting System seen at our institution between July 2002 and March 2014. VTE was defined using the International Classification of Diseases, 10th revision (ICD-10CM) codes for deep venous thrombosis (DVT), and pulmonary embolism (PE) whereas MB was defined using codes for intracerebral hemorrhage, subarachnoid hemorrhage, subdural hemorrhage, upper, and lower gastrointestinal bleeding. A random sample of 50 patients was obtained for each condition. Two abstractors independently conducted blinded diagnostic adjudication using standard criteria. Agreement was calculated using kappa statistics. Positive predictive values were calculated for VTE, MB and each diagnosis. RESULTS: Overall, ICD-10CM codes demonstrated very good ability to identify major bleeding events (PPV 88%). Diagnostic codes performed particularly well for all intracranial and lower gastrointestinal bleeds. In contrast, ICD-10CM codes for VTE had moderate ability (PPV 49%). Diagnostic codes for PE performed better than those for DVT. CONCLUSION: Single ICD-10CM codes for venous thromboembolism have moderate predictive value for identifying DVT and PE in emergency room discharges. In contrast, codes for MB events have very good ability and it would be adequate to use them for research purposes.
Authors: Rohit B Sangal; Samah Fodeh; Andrew Taylor; Craig Rothenberg; Emily B Finn; Kevin Sheth; Charles Matouk; Andrew Ulrich; Vivek Parwani; John Sather; Arjun Venkatesh Journal: J Stroke Cerebrovasc Dis Date: 2020-10-15 Impact factor: 2.136
Authors: Patricia O Guimarães; Arun Krishnamoorthy; Lisa A Kaltenbach; Kevin J Anstrom; Mark B Effron; Daniel B Mark; Patrick L McCollam; Linda Davidson-Ray; Eric D Peterson; Tracy Y Wang Journal: JAMA Cardiol Date: 2017-07-01 Impact factor: 14.676
Authors: Rachel Jeong; Robert R Quinn; Pietro Ravani; Feng Ye; Manish M Sood; David Massicotte-Azarniouch; Marcello Tonelli; Brenda R Hemmelgarn; Ngan N Lam Journal: Can J Kidney Health Dis Date: 2020-10-08
Authors: K M Sauro; A Soo; A Kramer; P Couillard; J Kromm; D Zygun; D J Niven; S M Bagshaw; H T Stelfox Journal: Neurocrit Care Date: 2019-04 Impact factor: 3.210
Authors: Christine Baumgartner; Alan S Go; Dongjie Fan; Sue Hee Sung; Daniel M Witt; John R Schmelzer; Marc S Williams; Steven H Yale; Jeffrey J VanWormer; Margaret C Fang Journal: Thromb Res Date: 2020-03-05 Impact factor: 3.944
Authors: Khara Sauro; Sean M Bagshaw; Daniel Niven; Andrea Soo; Rebecca Brundin-Mather; Jeanna Parsons Leigh; Deborah J Cook; Henry Thomas Stelfox Journal: BMJ Open Date: 2019-03-15 Impact factor: 2.692
Authors: Ayub Akbari; Elizabeth Kunkel; Sarah E Bota; Ziv Harel; Gregoire Le Gal; Conor Cox; Gregory L Hundemer; Mark Canney; Edward Clark; David Massicotte-Azarniouch; Anan Bader Eddeen; Greg Knoll; Manish M Sood Journal: Clin Kidney J Date: 2021-01-11